In a move that some experts are calling “reckless,” Pathway Genomics will begin selling genetic testing kits in 6,000 Walgreens stores, ostensibly allowing consumers to screen themselves for the tendency to develop such diseases and conditions as Alzheimer’s, breast cancer and obesity.